• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULA; AORTIC PERFUSION CANNULAE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULA; AORTIC PERFUSION CANNULAE Back to Search Results
Model Number EZC21TA
Device Problem Particulates (1451)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/07/2021
Event Type  malfunction  
Manufacturer Narrative
Additional manufacturer narrative: the device was returned to edwards for evaluation.Evaluation is in progress.A supplemental mdr will be submitted once additional information is available.This event is related to mfr report number 2015691-2021-02220.
 
Event Description
It was reported that a cannula had black residual inside of the cannula.There was no patient injury.As reported, during the de airing process, the physician noticed a few black specks on the inside of the cannula.The residue did not come out with back bleed.With a tip of forceps, it came out.Due to concern, the physician changed it.
 
Event Description
It was reported that a cannula had black residual inside of the cannula.Particulate on the cannula was noticed after insertion while trying to de-air it with blood in it during a mitral valve repair procedure.There was no patient injury.As reported, during the de airing process, the physician noticed a few black specks near the upper third of the inside of the cannula.Initially, the surgeon thought it was on the wall.Per the surgeon, it was almost the wording outside leaking to inside.The residue did not come out with back bleed.With a tip of forceps, it came out.Due to concern, the physician changed it.Per received records, this case involved a 58 year old female undergoing urgent mitral valve repair.Median sternotomy was done and the blood pressure was brought to 80 as the aorta was very close to the sternum.The pericardium was open and epiaortic ultrasound showed clean ascending aorta.Aortic and the bicaval cannulation was done.The systolic blood pressures were 80 at the time of cannulation.At this time the surgeon noticed that there were some black particles inside the aortic cannula.These were coming off and he felt it was better to change the cannula.A non-edwards cannula was used in replacement.
 
Manufacturer Narrative
H3.Device evaluation: customer complaint of an "black residual inside of the cannula" was unable to be confirmed.Device was returned with visible traces of blood.Returned device was examined by two different lab personnel under 3x magnification; reported loose particulate could not be found in the as received condition.Unknown contamination, which appeared to be blood residue, were found along the inside wire-reinforced area of the cannula and the non-wired section.A sample was sent to chemistry lab for ft-ir analysis.The ft-ir spectrum showed similar absorption characteristics to purified zein like material.H10.Additional manufacturer narrative: updated sections b5, d4-expiration date, h4, and h6 (type of investigation).The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.
 
Manufacturer Narrative
Updated section h6 (type of investigation, findings, conclusions).Complaint is confirmed by medical records.However, based on what was returned and evaluated, it cannot be confirmed that the reported particulate was returned or what the source of the reported particulate was.There is no evidence of an edwards/supplier manufacturing defect.Corrective actions are not required.Based on the ftir results, the observed contamination may have been blood as observed visually in product evaluation; it cannot be confirmed that the reported particulate was returned or what the source of the reported particulate was.Given the provided information and testing of the returned device, a definitive root cause cannot be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EZ GLIDE AORTIC CANNULA
Type of Device
AORTIC PERFUSION CANNULAE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key11606785
MDR Text Key245234433
Report Number2015691-2021-02221
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
PMA/PMN Number
K123370
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 06/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date09/24/2023
Device Model NumberEZC21TA
Device Lot Number283500
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/16/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/08/2021
Initial Date FDA Received04/02/2021
Supplement Dates Manufacturer Received04/02/2021
06/08/2021
Supplement Dates FDA Received04/27/2021
06/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-